Abstract
Study objective-To assess whether long term inhibition of angiotensin converting enzyme with captopril and frusemide or bendrofluazine protects kidney function in diabetic nephropathy.
Design -Non-randomised controlled before-after trial of matched hypertensive insulin dependent diabetics with nephropathy treated with captopril and frusemide or bendrofluazide.
Setting-Outpatient diabetic clinic in tertiary referral centre.
Patients-Treatment group of 18 hypertensive insulin dependent diabetics with nephropathy (mean age 33), who had not been treated previously. Control group of 13 patients (mean age 32) fulfilling the same entry criteria from a prospective study Interventions-Treatment group was given daily captopril 37-5-100-0 mg and frusemide (mean) 98 mg (10 patients) (1) (2) [tg/min; and mean glomerular filtration rate 98 (SE 5) ml/min/1 73 m2 v 96 (6) ml/min/1-73 M2. Mean arterial blood pressure fell by (1-3) mm Hg with captopril and rose by (1.5) mm Hg in controls, (p<0-001);
Albumin excretion decreased to 390 (1.1) [tg/min with captopril and rose to 1367 (1. 3) [tg/min in controls (p<0-001). The rate of decrease in glomerular filtration rate was lower with captopril (5.8 (0.7) ml/year v 10-0 (1-3) ml/year) (p<0.01). Rate of fall in
Introduction
Renal failure due to diabetic nephropathy is the main cause of death in patients with insulin dependent diabetes,'2 and on average death occurs seven years after the start of persistent albuminuria.' Increased arterial pressure is an early and common occurrence in diabetic nephropathy. 4 Systemic hypertension when transmitted to the glomerular capillary network results in glomerular capillary hypertension,5 which has also been shown in normotensive rats with diabetes that had been induced by streptozotocin.67 A link between glomerular hypertension and albuminuria and the development and progression of diabetic glomerulopathy has been suggested.89 In rats infusion of angiotensin II induced glomerular hypertension and albuminuria. ' °W e have shown that glomerular filtration rate is not dependent on angiotensin II and that inhibiting angiotensin converting enzyme with captopril for one week reduces albuminuria in hypertensive insulin dependent diabetics with nephropathy." We present here our findings on the long term effect of captopril on glomerular filtration rate and albuminuria in such patients.
Patients and methods

PATIENTS
We examined the records of all patients with insulin dependent diabetes who had proteinuria (those positive on dipstick testing) who were visiting the outpatient clinic at this hospital during 1984. 2 We invited all hypertensive patients to join the study if they were aged under 50; had persistent albuminuria (>300 mg albumin/day) and a serum creatinine concentration less than 120 tmolI and no oedema; and developed diabetes before the age of 31 but were not receiving antihypertensive treatment (including diuretics) and were not blind. Twenty patients fulfilled these criteria and all gave fully informed consent. At the start of the study one patient was excluded because treatment with thiazides had been started for oedema. One man was excluded after nearly one year's investigation because a renal biospy showed mesangioproliferative glomerulonephritis superimposed on a diffuse diabetic glomerulosclerosis.
Eighteen patients were studied. Apart from the first three patients (cases 1-3), who initially received combined treatment with captopril and a diuretic, all the remaining 15 patients were initially included in a randomised controlled trial to investigate the effect of F  40  28  Proliferative  0-54  20 5  6-0  Captopril 100, frusemide 80  2  M  37  16  Proliferative  0-52  21 9  10-0  Captopril 100, frusemide 40  3  F  29  13  Simplex  0-64  24-3  8-0  Captopril 100, frusemide 80  4  M  43  20  Proliferative  0 49  24-6  8-8  Captopril 100, bendrofluazide 5  5  M  34  18  Proliferative  0-55  23-9  9-2  Captopril 100, frusemide 40  6  M  46  20  Proliferative  0-63  23-9  8-0  Captopril 75, frusemide investigations, during which they rested supine and stood up only to pass urine. They drank 150-200 ml tap water/hour during the study. The investigations were carried out six to eight times during 27-36 (mean 31) months in the treated group and four to 13 (mean eight) times during 23-66 (mean 33) months in the-untreated group. The untreated group was investigated every six months whereas the treated group was studied after one week, after three months, and then every six months.
To measure the glomerular filtration rate we gave the patients a single intravenous injection of edetic acid labelled with 37 MBq sodium chromate-5 1 at 0900 and determined the radioactivity in plasma from samples of venous blood taken from the other arm 180, 200, 220, and 240 minutes after the injection."' The results were standardised for 1-73 m2 body surface area, using the patients' surface area at the start of the study. The mean coefficient ofvariation in the glomerular filtration rate of each patient from day to day was 4%.
Urinary albumin excretion was measured during the four hour clearance period by radioimmunoassay in the treated group'6 and by radial immunodiffusion in the untreated group."' The assays had a sensitivity of 0 5 mg/l and 2 mg/l, respectively, and a coefficient of variation between assays of 9% and 8%, respectively. Albumin concentration was measured simultaneously by both methods in urine collected from 27 of the patients with insulin dependent diabetes. The urinary albumin excretion rate ranged from 19 (between 1400 and 1600) after the patient had been supine for 10 minutes or more. Diastolic blood pressure was recorded at the disappearance of the Korotkoff sounds (phase V). 
Results
The two groups were well matched with respect to sex, age, duration of diabetes, retinopathy, insulin dose, body mass index, and energy intake ( BMJ VOLUME 297 untreated groups (10-2 (0-5) mmol/I and 10-6 (0-5) mmol/l, respectively). Haemoglobin Alc concentration remained unchanged in the treated group (fig 3) . The diet and body weight of the patients were also unchanged in both groups; average protein intake was 1 1 (0-07) g/kg/day in the treated patients. 14 as was also shown in our untreated control group.
The study was not a double blind randomised parallel control trial, which is the ideal design. Such a trial, however, can no longer be considered to be ethical in hypertensive insulin dependent diabetics with nephropathy because "self controlled" studies have We did, however, apply identical criteria for inclusion and exclusion of patients, which resulted in two well matched groups. Recommended energy intake and diet were about the same in both. Furthermore, intake of salt and protein was not restricted in either, and the 24 30 urinary excretion of sodium (intake) was quite high in the group receiving captopril (fig 4) . nephropathy taking normal diabetic diet (I *3 g/kg/day and 1*1 g/kg/day, respectively).25 26 Finally, the method used to determine glomerular filtration rate was identical in the two groups and the two techniques used for measuring urinary albumin concentration gave nearly the same result. These findings suggest that the comparison of the treated and untreated group is valid, though the possibility of a change in the natural course of the disease cannot entirely be ruled out.
Increased blood pressure is a common finding even early in the course of diabetic nephropathy.4 "' Sodium and water retention play a dominant part in initiating and maintaining hypertension in diabetic nephropathy, while the contribution from the renin-angiotensinaldosterone system is smaller.2728 The predominant action of angiotensin II is confined to the efferent arteriole, thereby inducing increased pressure in the glomerular capillaries.29 Conversely, inhibition of angiotensin converting enzyme diminishes this pressure in animals30 and probably also in humans, as reflected by a drop in the filtration fraction.3' 32 In a one week randomised single blind trial of captopril versus placebo we showed that glomerular filtration rate in diabetic nephropathy was not dependent on angiotensin II and that captopril reduced albuminuria, probably by lowering glomerular hypertension." These findings led us to investigate the long term effect of a combined treatment with captopril and a diuretic in hypertensive insulin dependent diabetics with nephropathy.
Systemic and glomerular hypertension enhance albuminuria and the development of diabetic glomerulopathy and accelerate the decrease in glomerular filtration rate in diabetic nephropathy.89 [33] [34] [35] [36] terised by effectiveness, safety, and maintenance of the quality of life. The present treatment was effective, and as the adverse effects were only minimal all patients continued to take it. The quality of life was less affected by the present treatment than by f3 blockers with or without a diuretic. 
